The effect of ligand type and density on osteoblast adhesion, proliferation, and matrix mineralization

Journal of Biomedical Materials Research - Part A

Volumn 75, Issue 4, 2005, Pages 855-869

  Harbers, Gregory M ^a,b   Healy, Kevin E ^b,c  

^a Northwestern University   (United States)

^b University of California at Berkeley   (United States)

^c No 1760   (United States)

Author keywords

Adhesion (centrifugation assay); Mineralization; Osteoblast; Polymer coating (IPN); RGD peptide

Indexed keywords

ADHESION; MOLECULAR STRUCTURE; POLYPEPTIDES; PROTEINS; STRENGTH OF MATERIALS; STYRENE;

ADHESION (CENTRIFUGATION ASSAY); MINERALIZATION; OSTEOBLAST; POLYMER COATING (IPN); RGD PEPTIDES;

BONE;

ARGINYLGLYCYLASPARTIC ACID; BINDING PROTEIN; BIOMATERIAL; COLLAGEN; COLLAGEN BINDING PROTEIN; CYCLOPEPTIDE; HEPARIN BINDING PROTEIN; LIGAND; POLY(ACRYLAMIDE CO ETHYLENE GLYCOL ACRYLIC ACID); POLYMER; POLYSTYRENE; SIALOPROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALVARIA; CELL ADHESION; CELL PROLIFERATION; CENTRIFUGATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MINERALIZATION; NONHUMAN; OSTEOBLAST; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; STEM CELL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; LIGANDS; OLIGOPEPTIDES; OSTEOBLASTS; RATS; SKULL;

EID: 28844489128     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30482     Document Type: Article

References (45)

1. Barber TA, Golledge SL, Castner DG, Healy KE. Peptide-modified p(AAm-co-EG/AAc) IPNs grafted to bulk titanium modulate osteoblast behavior in vitro. J Biomed Mater Res 2003;64:38-47.
2. Rezania A, Healy KE. The effect of peptide surface density on the mineralization of matrix deposited by osteogenic cells. J Biomed Mater Res 2000;52:595-600.
3. Dee KC, Anderson TT, Bizios R. Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials. J Biomed Mater Res 1998;40:371-377.
4. Massia SP, Hubbell JA. Covalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates. Anal Biochem 1990;187:292-301.
5. Rezania A, Healy KE. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotech Prog 1999;15:19-32.
6. Hersel U, Dahmen C, Kessler H. Rgd modified polymers: Biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003;24:4385-4415.
7. Bearinger JP, Castner DG, Healy KE. Biomolecular modification of p(AAm-co-EG/AAc) IPNs supports osteoblast adhesion and phenotypic expression. J Biomater Sci Poly Ed 1998; 9:629-652.
8. Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, Horwitz AF. Integrin-ligand binding properties govern cell migration speed through cell-substartum adhesiveness. Nature 1997;385:537-540.
9. Asthagiri AR, Nelson CM, Horwitz AF, Lauffenburger DA. Quantitative relationship among integrin-ligand binding, adhesion, and signaling via focal adhesion kinase and extracellular signal-regulated kinase 2. J Biol Chem 1999;274:27119-27127.
10. Garcia AJ, Huber F, Boettiger D. Force required to break alpha5beta1 integrin-fibronectin bonds in intact adherent cells is sensitive to integrin activation state. J Biol Chem 1998;273: 10988-10993.
11. Xiao G, Wang D, Benson DM, Karsenty G, Franceschi RT. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the osf2 transcription factor. J Biol Chem 1998;273:32988-32994.
12. Reyes CD, Garcia AJ. Alpha2beta1 integrin-specific collagen-mimetic surfaces supporting osteoblastic differentiation. J Biomed Mater Res 2004;69A:591-600.
13. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002;17:101-110.
14. Franceschi RT, Xiao G, Jiang D, Gopalakrishnan R, Yang S, Reith E. Multiple signaling pathways converge on the cbfa1/ runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res 2003;44(Suppl 1):109-116.
15. Gersbach CA, Byers BA, Pavlath GK, Garcia AJ. Runx2/cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp Cell Res 2004; 300:406-417.
16. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT. Mapk pathways activate and phosphorylate the osteoblast-specific transcription factor, cbfa1. J Biol Chem 2000; 275:4453-4459.
17. Rezania A, Healy KE. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res 1999;17:615-623.
18. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE. The detachment strength and morphology of bone cells contacting materials modified with a peptide derived from bone sialoprotein. J Biomed Mater Res 1997;37:9-19.
19. Harbers GM, Gamble LJ, Irwin EF, Castner DG, Healy KE. Development and characterization of a high-throughput system for assessing cell surface receptor-ligand engagement. Langmuir 2005;21(18):8374-8384.
20. Irwin EF, Ho JE, Kane SR, Healy KE. Analysis of interpenetrating polymer networks via quartz crystal microbalance with dissipation monitoring. Langmuir 2005;21:5529-5536.
21. Pierschbacher MD, Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem 1987;262:17294-17298.
22. Ivaska J, Kapyla J, Pentikainen O, Hoffren AM, Hermonen J, Huttunen P, Johnson MS, Heino J. A peptide inhibiting the collagen binding function of integrin alpha21 domain. J Biol Chem 1999;274:3513-3521.
23. van der Pluijm G, Vloedgraven HJ, Ivanov B, Robey FA, Grzesik WJ, Robey PG, Papapoulos SE, Lowik CW. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res 1996;56:1948-1955.
24. Laterra J, Silbert JE, Culp LA. Cell surface heparan sulfate mediates some adhesive responses to glycosaminoglycan-binding matrices, including fibronectin. J Cell Biol 1983;96:112-123.
25. Woods A, Couchman JR, Johansson S, Hook M. Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J 1986;5:665-670.
26. Dalton BA, McFarland CD, Underwood PA, Steele JG. Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells. J Cell Sci 1995;108: 2083-2092.
27. Barber TA, Harbers GM, Park S, Gilbert M, Healy KE. Ligand density characterization of peptide-modified biomaterials. Biomaterials 2005;26(34):6897-6905.
28. Healy KE, Thomas CH, Rezania A, Kim JE, McKeown PJ, Lom B, Hockberger PE. Kinetics of bone cell organization and mineralization on materials with patterned surface chemistry. Biomaterials 1996;17:195-208.
29. Whitson SW, Whitson MA, Bowers DE, Falk MC. Factors influencing synthesis and mineralization of bone matrix from fetal bovine bone cells grown in vitro. J Bone Miner Res 1992; 7:727-741.
30. McClay DR, Wessel GM, Marchase RB. Intercellular recognition: Quantitation of initial binding events. Proc Natl Acad Sci USA 1981;78:4975-4979.
31. Dickson GR. Methods of calcified tissue preparation. New York: Elsevier; 1984.
32. Glantz SA. Primer of biostatistics. New York: McGraw-Hill Co., Inc.; 1997.
33. Thieme HR. Classic models of density-dependent population growth for single species. Mathematics in population biology. Princeton: Princeton University Press; 2003. p 37-39.
34. Hautanen A, Gailit J, Mann DM, Ruoslahti E. Effects of modification of the rgd sequence and its context on recognition by the fibronectin receptor. J Biol Chem 1989;264:1437-1442.
35. Maeda T, Hashino K, Oyama R, Titani K, Sekiguchi K. Artificial cell adhesive proteins engineered by grafting the Arg-Gly-Asp cell recognition signal: Factors modulating the cell adhesive activity of the grafted signal. J Biochem 1991;110:381-387.
36. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984;309:30-33.
37. Sato M, Garsky V, Majeska RJ, Einhorn TA, Murray J, Tashjian AH Jr, Gould RJ. Structure-activity studies of s-echistatin inhibition of bone resorption. J Bone Miner Res 1994;9:1441-1449.
38. van der Pluijm G, Vloedgraven HJ, Ivanov B, Robey FA, Grzesik WJ, Robey PG, Papapoulos SE, Lowik CW. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res 1996;56:1948-1955.
39. Horton MA, Dorey EL, Nesbitt SA, Samanen J, Ali FE, Stadel JM, Nichols A, Greig R, Helfrich MH. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: A structure-function analysis. J Bone Miner Res 1993;8: 239-247.
40. Shapiro HS, Chen J, Wrana JL, Zhang Q, Blum M, Sodek J. Characterization of porcine bone sialoprotein: Primary structure and cellular expression. Matrix 1993;13:431-440.
41. Rapuano BE, Wu C, MacDonald DE. Osteoblast-like cell adhesion to bone sialoprotein peptides. J Orthop Res 2004;22:353-361.
42. Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. The collagen-binding A-domains of integrins alpha1beta1 and alpha2beta1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem 2000;275:35-40.
43. Reyes CD, Garcia AJ. Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide. J Biomed Mater Res 2003;65A:511-523.
44. Bellows CG, Aubin JE, Heersche JN, Antosz ME. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986;38:143-154.
45. Bonewald LF, Harris SE, Rosser J, Dallas MR, Dallas SL, Camacho NP, Boyan B, Boskey A. Von kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int 2003;72:537-547.